Wilson disease

[1] Hepatobiliary transport: Molecular mechanisms of development and cholestasis [J]. PEDIATRIC RESEARCH, 1998, 44 (02) : 141 - 147

[2] Asonuma K, 1999, Pediatr Transplant, V3, P201, DOI 10.1034/j.1399-3046.1999.00014.x

[3] BEARN AG, 1960, ANN HUM GENET, V24, P33

[4] LIVER-TRANSPLANTATION FOR WILSONS-DISEASE [J]. JOURNAL OF HEPATOLOGY, 1995, 23 (04): : 373 - 381

[5] Bramwell B., 1916, EDINB MED J, V17, P90

[6] Recognition, diagnosis, and management of Wilson's disease [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 223 (01): : 39 - 46

[7] Treatment of Wilson's disease with zinc [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 134 (03): : 322 - 324

[8] Treatment of Wilson disease with ammonium tetrathiomolybdate - III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy [J]. ARCHIVES OF NEUROLOGY, 2003, 60 (03) : 379 - 385

[9] Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (09) : 1665 - 1671

[10] THE WILSON DISEASE GENE IS A PUTATIVE COPPER TRANSPORTING P-TYPE ATPASE SIMILAR TO THE MENKES GENE [J]. NATURE GENETICS, 1993, 5 (04) : 327 - 337

[1] Hepatobiliary transport: Molecular mechanisms of development and cholestasis [J]. PEDIATRIC RESEARCH, 1998, 44 (02) : 141 - 147

[2] Asonuma K, 1999, Pediatr Transplant, V3, P201, DOI 10.1034/j.1399-3046.1999.00014.x

[3] BEARN AG, 1960, ANN HUM GENET, V24, P33

[4] LIVER-TRANSPLANTATION FOR WILSONS-DISEASE [J]. JOURNAL OF HEPATOLOGY, 1995, 23 (04): : 373 - 381

[5] Bramwell B., 1916, EDINB MED J, V17, P90

[6] Recognition, diagnosis, and management of Wilson's disease [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 223 (01): : 39 - 46

[7] Treatment of Wilson's disease with zinc [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 134 (03): : 322 - 324

[8] Treatment of Wilson disease with ammonium tetrathiomolybdate - III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy [J]. ARCHIVES OF NEUROLOGY, 2003, 60 (03) : 379 - 385

[9] Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (09) : 1665 - 1671

[10] THE WILSON DISEASE GENE IS A PUTATIVE COPPER TRANSPORTING P-TYPE ATPASE SIMILAR TO THE MENKES GENE [J]. NATURE GENETICS, 1993, 5 (04) : 327 - 337